Erika Costa de Alvarenga

Dr. Erika Costa de Alvarenga

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MDMaria E. Danoviz
Maria E. Danoviz
JNJuliana S. Nakamuta
Juliana S. Nakamuta
Fabio Luiz Navarro MarquesFabio Luiz Navarro Marques
Fabio Luiz Navarro Marques
LSLeonardo dos Santos
Leonardo dos Santos
EAErika Costa de Alvarenga
Erika Costa de Alvarenga
JKJose Krieger
Jose Krieger
Cardiac cell transplantation is compromised by low cell retention and poor graft viability. Here, the effects of co-injecting adipose tissue-derived stem cells (ASCs) with biopolymers on cell cardiac retention, ventricular morphometry and performance were evaluated in a rat model of myocardial infarction (MI). 99mTc-labeled ASCs (1×106 cells) isolated from isogenic Lewis rats were injected 24 hours post-MI using fibrin a, collagen (ASC/C), or culture medium (ASC/M) as vehicle, and cell body distribution was assessed 24 hours later by γ-emission counting of harvested organs. ASC/F and ASC/C groups retained significantly more cells in the myocardium than ASC/M (13.8±2.0 and 26.8±2.4% vs. 4.8±0.7%, respectively). Then, morphometric and direct cardiac functional parameters were evaluated 4 weeks post-MI cell injection. Left ventricle (LV) perimeter and percentage of interstitial collagen in the spare myocardium were significantly attenuated in all ASC-treated groups compared to the non-treated (NT) and control groups (culture medium, fibrin, or collagen alone). Direct hemodynamic assessment under pharmacological stress showed that stroke volume (SV) and left ventricle end-diastolic pressure were preserved in ASC-treated groups regardless of the vehicle used to deliver ASCs. Stroke work (SW), a global index of cardiac function, improved in ASC/M while it normalized when biopolymers were co-injected with ASCs. A positive correlation was observed between cardiac ASCs retention and preservation of SV and improvement in SW post-MI under hemodynamic stress. We provided direct evidence that intramyocardial injection of ASCs mitigates the negative cardiac remodeling and preserves ventricular function post-MI in rats and these beneficial effects can be further enhanced by administrating co-injection of ASCs with biopolymers.

1 February 2010 in Bone
Verified
Journal Article
Closed access
EAErika Costa de Alvarenga
Erika Costa de Alvarenga
RRRenata Rodrigues
Renata Rodrigues
ACAfonso Caricati-Neto
Afonso Caricati-Neto
FSFernando Costa Silva-Filho
Fernando Costa Silva-Filho
EGEdgar Julian Paredes Gamero
Edgar Julian Paredes Gamero
AFAlice T. Ferreira
Alice T. Ferreira

30 April 2018 in Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
WSWalison N. Silva
Walison N. Silva
PPPedro H. D. M. Prazeres
Pedro H. D. M. Prazeres
APAna E. Paiva
Ana E. Paiva
LLLuiza Lousado
Luiza Lousado
ATAnaelise O. M. Turquetti
Anaelise O. M. Turquetti
Alexander BirbrairAlexander Birbrair
Alexander Birbrair

1 December 2019 in Measurement
Verified
Journal Article
Closed access
TSTalysson Santos
Talysson Santos
MBMárcio Falcão Santos Barroso
Márcio Falcão Santos Barroso
RRRodrigo A. Ricco
Rodrigo A. Ricco
Erivelton NepomucenoErivelton Nepomuceno
Erivelton Nepomuceno
EAErika Costa de Alvarenga
Erika Costa de Alvarenga
ASAna F. Santos
Ana F. Santos

1 November 2016 in Cellular Signalling
Verified
Journal Article
Closed access
RVRebecca Vasconcellos
Rebecca Vasconcellos
EAErika Costa de Alvarenga
Erika Costa de Alvarenga
RPRicardo C. Parreira
Ricardo C. Parreira
SLSwiany S. Lima
Swiany S. Lima
RRRodrigo Resende
Rodrigo Resende

1 May 2011 in Hypertension
Verified
Journal Article
Closed access
PGPaola B. Guimarães
Paola B. Guimarães
EAErika Costa de Alvarenga
Erika Costa de Alvarenga
PSPaula D. Siqueira
Paula D. Siqueira
EGEdgar Julian Paredes Gamero
Edgar Julian Paredes Gamero
RSRegiane A. Sabatini
Regiane A. Sabatini
JPJoão B. Pesquero
João B. Pesquero
Angiotensin (Ang) I–converting enzyme (ACE) is involved in the control of blood pressure by catalyzing the conversion of Ang I into the vasoconstrictor Ang II and degrading the vasodilator peptide bradykinin. Human ACE also functions as a signal transduction molecule, and the binding of ACE substrates or its inhibitors initiates a series of events. In this study, we examined whether Ang II could bind to ACE generating calcium signaling. Chinese hamster ovary cells transfected with an ACE expression vector reveal that Ang II is able to bind with high affinity to ACE in the absence of the Ang II type 1 and type 2 receptors and to activate intracellular signaling pathways, such as inositol 1,4,5-trisphosphate and calcium. These effects could be blocked by the ACE inhibitor, lisinopril. Calcium mobilization was specific for Ang II, because other ACE substrates or products, namely Ang 1-7, bradykinin, bradykinin 1-5, and N -acetyl-seryl-aspartyl-lysyl-proline, did not trigger this signaling pathway. Moreover, in Tm5, a mouse melanoma cell line endogenously expressing ACE but not Ang II type 1 or type 2 receptors, Ang II increased intracellular calcium and reactive oxygen species. In conclusion, we describe for the first time that Ang II can interact with ACE and evoke calcium and other signaling molecules in cells expressing only ACE. These findings uncover a new mechanism of Ang II action and have implications for the understanding of the renin-Ang system.